Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group

Research output: Contribution to journalArticlepeer-review

217 Citations (Scopus)
3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial'. Together they form a unique fingerprint.

Medicine & Life Sciences